Director, HEOR Analytics, USMA

Basking Ridge, New Jersey
Jul 09, 2021
Pharm Country
Required Education
Bachelors Degree
Position Type
Full time
Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Serve as an analytical expert to the HEOR team and supports scientifically rigorous outcomes research and development of documents for external dissemination.

  • Work with HEOR therapeutic/product lead to develop study protocol and statistical analysis plans for observational studies, health outcomes and economic analyses to support pipeline and marketed products. Create datasets from large healthcare databases of claims and electronic health records and develop statistical programs. Conduct descriptive and inferential statistical analyses and generate results for study reports and publications. Perform QA to ensure validity of study results. Identify issues, troubleshooting gaps, and resolve anomalies.
  • Manage healthcare database licenses acquired by the HEOR team and budget. Update data as needed. Ensure compliance to contractual terms and renew licenses as appropriate. Work with IT to ensure sufficient hardware, software and data security requirements are in place.
  • Work with HEOR therapeutic/product lead to develop study protocols and statistical analysis plans for economic and patient-reported outcomes endpoints in Phase 2, 3 and 4 clinical studies. Analyze HEOR data from clinical studies for inclusion in clinical study reports, value dossiers and publications. Conduct post-hoc analyses of clinical data as necessary to develop value proposition for external stakeholders. Partner with HEOR professionals to develop scientifically rigorous documents for external dissemination.
  • Review study protocols, statistical analysis plans of HEOR data to optimize study design and data collection generated by external research partners. Review study reports and perform QA to ensure validity of study results.

Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education Qualifications (from an accredited college or university)
PhD preferred Advanced degree in biostatistics/relevant field preferred
Experience Qualifications
  • 10 or More Years experience in the pharmaceutical industry or consulting organization. preferred
  • Relevant experience in programming, analysis and interpretation of clinical study and retrospective data. preferred
  • Analytical experience in cardiovascular, pain and oncology preferred

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.